Inflammatory Disease News and Research

RSS

IUPUI scientists develop new synthetic method to shorten drug discovery and development process

Synthesizing useful new compounds is what pharmaceutical discovery and development is all about. Researchers at the School of Science at Indiana University-Purdue University Indianapolis have devised a method to substantially speed up the process.

1 Dec 2016

Study suggests new approach to treat white blood cells of sepsis patients

New research findings published in the Journal of Leukocyte Biology, suggest that treating the white blood cells of sepsis patients with antibodies that block programmed cell death-1 (PD-1) and programmed cell death ligand (PD-L1) molecules may restore their function and ultimately their ability to eradicate deadly bacteria.

1 Dec 2016

FDG PET-CT imaging helps assess anatomical structure and metabolic activity in patients with GLILD

A new proof of concept study has shown that an imaging technique more commonly used to assess cancer patients may also be of help in assessing disease and treatment effects in patients with inflammatory diseases.

30 Nov 2016

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

Researchers at University of California San Diego School of Medicine have shown that ustekinumab, a human antibody used to treat arthritis, significantly induces response and remission in patients with moderate to severe Crohn's disease.

17 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

Researchers create new culture model of human intestine to study inflammatory bowel disease

Inflammatory bowel disease (IBD) is a complex condition that requires a lifetime of care and increases a person's cancer risk.

2 Nov 2016

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

24 Sep 2016

Research findings may help better understand genetic origins of Familial Mediterranean Fever

A team of scientists led by Stony Brook University researchers have discovered a new mechanism for a bacterial toxin to inhibit inflammation.

19 Sep 2016

Research findings may pave way for innovative treatments of multiple sclerosis

Researchers at the Research Center for Immunotherapy and the Focus Program Translational Neurosciences of Johannes Gutenberg University Mainz have identified a new mechanism that is involved in the development of autoimmune diseases.

14 Sep 2016

Researchers develop method to predict disease activity in multiple sclerosis

Cells in the immune system of patients with multiple sclerosis behave differently from those of healthy individuals. Researchers at Linköping University in Sweden have exploited this difference to develop a method that can predict disease activity in multiple sclerosis.

14 Sep 2016

BetterYou welcomes research linking low vitamin D levels to asthma attacks

A daily oral sunshine spray could be the answer to halving the risk of severe asthma attacks, after a recent study suggested that taking a vitamin D supplement can help by reducing inflammation in the lungs and warding off viruses.

From BetterYou Ltd 8 Sep 2016

STDs are becoming more difficult to treat due to antibiotic resistance, warns WHO

The WHO has issued new guidelines for the treatment of three common sexually transmitted diseases (STDs) due to concerns about increasing levels of antibiotic resistance.

2 Sep 2016

LJI researchers reveal unanticipated way by which neutrophils defend against invading pathogens

As an arm of the innate immune system, white blood cells called neutrophils form the first line of defense against invading pathogens.

31 Aug 2016

Can-Fite BioPharma reports financial results, provides update on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2016 and updates on its drug development programs.

27 Aug 2016

Penn State dermatologist clarifies common myths about psoriasis

Psoriasis is a much-misunderstood disease, often kept under wraps by sufferers who want to hide their skin lesions.

26 Aug 2016

Non-coding RNAs play key role in maintaining proper balance between fighting infection and inflammation

Special RNA molecules called long non-coding RNAs (lncRNAs) are key controllers for maintaining immune health when fighting infection or preventing inflammatory disorders, according to research led by Jorge Henao-Mejia, MD, PhD, an assistant professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania.

25 Aug 2016

NIH researchers discover rare, lethal inflammatory disease that affects young children

National Institutes of Health researchers have discovered a rare and sometimes lethal inflammatory disease - otulipenia - that primarily affects young children. They have also identified anti-inflammatory treatments that ease some of the patients' symptoms: fever, skin rashes, diarrhea, joint pain and overall failure to grow or thrive.

23 Aug 2016

Inflammatory Disease News and Research

IUPUI scientists develop new synthetic method to shorten drug discovery and development process

Study suggests new approach to treat white blood cells of sepsis patients

FDG PET-CT imaging helps assess anatomical structure and metabolic activity in patients with GLILD

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Researchers create new culture model of human intestine to study inflammatory bowel disease

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Research findings may help better understand genetic origins of Familial Mediterranean Fever

Research findings may pave way for innovative treatments of multiple sclerosis

Researchers develop method to predict disease activity in multiple sclerosis

BetterYou welcomes research linking low vitamin D levels to asthma attacks

STDs are becoming more difficult to treat due to antibiotic resistance, warns WHO

LJI researchers reveal unanticipated way by which neutrophils defend against invading pathogens

Can-Fite BioPharma reports financial results, provides update on drug development programs

Penn State dermatologist clarifies common myths about psoriasis

Non-coding RNAs play key role in maintaining proper balance between fighting infection and inflammation

NIH researchers discover rare, lethal inflammatory disease that affects young children

DASH diet could be effective, non-pharmacologic approach to prevent gout flares

Hidden dental root tip infections may increase risk of coronary artery disease

Psoriasis treatments may help improve cardiovascular symptoms by reducing skin inflammation

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News